Hidradenitis Suppurativa

Study

Be part of the future of hidradenitis suppurativa

 

About the study sponsored by Diex Recherche:

Do you have hidradenitis suppurativa and are looking for a new treatment option?

Hidradenitis suppurativa is a chronic inflammatory skin disease characterized by painful nodules, abscesses and scars that significantly affect quality of life.

Although treatments exist, many patients do not find sufficient relief. This is why clinical research is exploring new therapeutic approaches, such as this new experimental treatment under study.

Why participate?

Contribute to the future of health: Your participation can lead to future treatments for this disease.

Access to quality care: Close medical monitoring, free examinations and personalized advice.

Financial compensation: Compensation is provided for eligible participants.

Who is eligible?

We invite to participate individuals who:

- Are aged 18 and over

- Have a confirmed diagnosis of hidradenitis suppurativa for at least 6 months

How does it work?

Pre-registration: Start by completing our online pre-registration form to help us determine if you may be eligible.

Initial Assessment: If you are considered pre-eligible, an invitation will be sent to you to come to our center for a detailed assessment.

Participation: After confirmation of your eligibility, you will receive all the information required to begin your participation in this study.

I want to apply to this clinical study

Québec

For more information, contact us at 581 477-3439 (Québec) or at 1-844-739-3439 (toll free), or fill the online form.

The study process in pictures

Explanation

Step 1 | Before starting the study, we will take time to fully explain the selection process and the conduct of the study by phone.

Meeting

Step 2 | After the initial phone interview, if you are still interested in taking part in a study, we schedule a preliminary meeting with you during which you may ask all the questions you wish and take the time you require to read over the consent form. This form explains, in detail, the different stages of each study.

Decision

Step 3 | You may make a decision at that time to move forward with or terminate the selection process. However, you are under no obligation to make an immediate decision. Based on briefing content, you may take the time necessary to come to a decision and consult with your personal physician or loved ones.

Tests

Step 4 | Depending on the nature of the study, some tests or medical examinations may be required. In the majority of cases, these tests or examinations are conducted on Diex Research premises based on your individual availability.

Departure

Step 5 | If you are eligible, you may then begin a clinical study with us.